With Novo Nordisk's Wegovy weight-loss drug in short supply, the company's owner agreed to buy contract manufacturer Catalent for $16.5 billion, including…
With Novo Nordisk's Wegovy weight-loss drug in short supply, the company's owner agreed to buy contract manufacturer Catalent for $16.5 billion, including…
Upworthy
0 shares
1 views
You might like
Related news coverage
Latest Weight-Loss Drug Faces Shortages
Wibbitz Top Stories
Latest Weight-Loss Drug , Faces Shortages .
The United States Food and Drug Administration
(FDA) says that high demand..